This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Digitalization is the new buzzword. It touches each and every aspect of our lives. How is it possible that the pharma and healthcare industry remains unaffected by it? In fact, being a technology-driven industry, it gets the most benefits of digital transformation. There are digital modes for better patient care. There are people willing to receive treatment and healthcare using the digital platform.
Overview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Healthcare systems are being put under significant pressure, at a time when many are already over-stretched, medical congresses are being cancelled and bans on non-essential travel and enforced home working are emerging.
Considering A Career In Pharmacy? All jobs intrinsically require more than the surface skills required. For example, a great teacher should not only have a bachelor's degree in education they should also have strong interpersonal skills to allow them to effectively teach. In an effort to define what makes a successful pharmacist, we asked three of our Indispensable Health pharmacists, “In Your Experience, What Are The Traits of Successful Pharmacists?
Fluvoxamine drug interactions can be clinically significant in clinical practice. It is a major reason why this medication is not used very often. If you ever see it on a medication list of one of your patients, you must do a drug interaction screen. According to the package insert, fluvoxamine can inhibit CYP1A2, CYP2C9, CYP3A4, […]. The post Fluvoxamine Drug Interactions appeared first on Med Ed 101.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Overview In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based on their target product profile alone. Instead, the key factor now is often the quality of customer engagement, which more and more healthcare professionals (HCPs) appear to value. It’s enabled by a multichannel marketing (MCM) approach, but traditional MCM strategies require a much higher level of content than pharma is used to producing and approving – the answe
The world is a buzz with COVID-19 news and rightfully so. I want to cover hydroxychloroquine clinical pearls. This drug has been purported to have activity against coronavirus. Here’s a link to that research article. Uses of Hydroxychloroquine While it is classified as an antimalarial agent, the most common, long term use for hydroxychloroquine that […].
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as well as data that NSAIDs may not be good […]. The post Avoid NSAIDs in COVID-19?
40
40
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as well as data that NSAIDs may not be good […]. The post Avoid NSAIDs in COVID-19?
Hey all, thanks so much for supporting the blog as well as the podcast! I’m amazed at how many people come to pick up a few pearls or listen to the drug of the week. Because of your support, I like to give annual sweet deals on our content! Today is the day for our […]. The post One Time Only! 50% Off 2020 NAPLEX Content appeared first on Med Ed 101.
Many patients will take acetaminophen for their pain management. It is cheap, somewhat effective, and typically pretty safe at normal dosages. There are potential downsides when it comes to acetaminophen. Let me outline a couple of common mistakes with acetaminophen. #1 Common Mistakes with Acetaminophen – Multiple Sources Many elderly patients do understand that acetaminophen […].
Tapering benzodiazepines or any drug for that matter is a bit of an art. Sure we do have some evidence on these types of topics, but we can’t also schedule a taper schedule perfectly based upon a percentage of the dose. Dosage forms and the patients themselves can throw a wrinkle into what we might […]. The post Tapering Benzodiazepines – Tricks of the Trade appeared first on Med Ed 101.
I received a question the other day about the use of bisphosphonates in patients who may have a limited life expectancy but have osteoporosis or are at risk for osteoporosis. It is a very good question and that determination is going to be made on a case by case basis. Arguably the biggest challenge with […]. The post Starting Bisphosphonates in Patients With Limited Life Expectancy appeared first on Med Ed 101.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content